<DOC>
	<DOCNO>NCT00004225</DOCNO>
	<brief_summary>RATIONALE : Inserting gene p53 person 's cancer cell may improve body 's ability fight cancer . Radiation therapy use high-energy x-rays damage tumor cell . PURPOSE : Phase I trial study effectiveness gene therapy plus radiation therapy treat patient non-small cell lung cancer .</brief_summary>
	<brief_title>Gene Therapy Plus Radiation Therapy Treating Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility tolerability adenovirus p53 gene therapy radiotherapy patient non-small cell lung cancer without prior radiotherapy indicator lesion ( ) . - Determine p53 p21 expression induction apoptosis necrosis patient treat regimen . - Assess vector incorporation , antitumor response , local control , viral dissemination , development adenovirus antibody patient treat regimen . OUTLINE : This multicenter study . Patients stratify prior radiotherapy indicator lesion ( ) ( yes v ) . Adenovirus p53 inject directly endobronchial lesion via bronchoscopy locoregional tumor via multiple percutaneous puncture fluoroscopic , ultrasonic , CT scan guidance day 1 , 3 , 8 . Patients undergo radiotherapy begin day 2 continue total 10 day . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 10 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove nonsmall cell lung cancer least 1 lesion accessible endobronchial percutaneous injection Measurable evaluable disease Must requirement palliative radiotherapy thorax Clinically stable enough undergo 3 adenovirus injection PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 0 1 Life expectancy : At least 12 week Hematopoietic : Platelet count great 100,000/mm^3 Hepatic : PT PTT normal Renal : Not specify Cardiovascular : No New York Heart Association class III IV heart disease Other : No active systemic viral , bacterial , fungal infection require treatment No concurrent illness require hospitalization IV medication psychologic , familial , sociologic , geographic , concurrent condition would preclude adequate follow compliance Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : No prior adenoviral gene therapy Any number type prior biologic therapy allow Chemotherapy : Any number type prior chemotherapy allow At least 2 week since prior systemic cancer therapy bad grade 2 toxicity organ Endocrine therapy : Any number type prior endocrine therapy allow Radiotherapy : See Disease Characteristics No prior radiotherapy great 50 Gy prior concurrent radiation field include spinal cord No prior radiotherapy fraction size great 2 Gy spinal cord concurrent radiation field Surgery : At least 4 week since surgical resection lung tissue At least 2 week since prior surgery require general anesthesia recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
</DOC>